Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit, Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS.
In: ENP Newswire, 2024-03-15
Zeitungsartikel
Zugriff:
Titel: |
Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit, Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS.
|
---|---|
Zeitschrift: | ENP Newswire, 2024-03-15 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|